by Pill Pals | Mar 5, 2025 | News
Summary Company Announcement Date: December 16, 2024 FDA Publish Date: December 18, 2024 Product Type: Food & Beverages Snack Food Item Allergens Reason for Announcement: Recall Reason Description Potential or Undeclared Allergen – Milk Company Name: Frito-Lay...
by Pill Pals | Mar 5, 2025 | News
Summary Company Announcement Date: February 07, 2025 FDA Publish Date: February 08, 2025 Product Type: Food & Beverages Foodborne Illness Reason for Announcement: Recall Reason Description Potential Foodborne Illness – Listeria monocytogenes Company Name: Jack...
by Pill Pals | Mar 5, 2025 | News
Recipient: Recipient Name Namita A. Goyal, MD Namita A. Goyal, M.D. UC Irvine Health200 S. Manchester Ave, Suite 110Orange, CA 92868-3214United States namitag@hs.uci.edu Issuing Office: Center for Biologics Evaluation and Research (CBER) United States Secondary...
by Pill Pals | Mar 5, 2025 | News
Summary Company Announcement Date: February 13, 2025 FDA Publish Date: February 14, 2025 Product Type: Drugs Reason for Announcement: Recall Reason Description Bags of POTASSIUM CHLORIDE Inj. 20 mEq have incorrect overwrap labels which state POTASSIUM CHLORIDE Inj. 10...
by Pill Pals | Mar 5, 2025 | News
EspañolThe U.S. Food and Drug Administration is warning consumers that the agency continues to receive adverse event reports related to selective androgen receptor modulators, commonly called SARMs. Social media posts by influencers and sellers of SARMs contribute to...
by Pill Pals | Mar 5, 2025 | News
Summary Company Announcement Date: December 19, 2024 FDA Publish Date: December 19, 2024 Product Type: Food & Beverages Allergens Reason for Announcement: Recall Reason Description Product may contain undeclared peanut Company Name: Orgain Brand Name: Product...